Search for: "United States v. Abbott Laboratories" Results 61 - 80 of 154
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jan 2013, 4:30 am by Scott A. McKeown
Kappos) Last week the Federal Circuit heard oral argument (here) in Abbott Laboratories v. [read post]
8 Jun 2012, 10:35 am by Bexis
  The underlying rationale for the validity of the learned intermediary doctrine remains just as viable today as stated by Judge Wisdom in 1974 [citations, inclulding block quote from Reyes v. [read post]
17 May 2012, 9:26 pm by FDABlog HPM
Butler – Abbott Laboratories (“Abbott”) recently submitted a citizen petition to FDA regarding biosimilars under the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”). [read post]
1 Feb 2012, 11:15 am by Sean Wajert
Abbott Laboratories, et al., No. 2:10-cv-03242 (E.D. [read post]
22 Dec 2011, 11:59 am by Bexis
  All this in a state – Illinois – where the highest court forbids FDCA-based common-law causes of action (see Martin v. [read post]
2 Dec 2011, 2:00 pm by Bexis
Abbott Laboratories, 2011 WL 4808166, at *4 (N.D. [read post]
26 Nov 2011, 4:46 pm
Abbott LaboratoriesCourt: U.S. 10th Circuit Court of Appeals Docket: 10-4185 November 22, 2011 Judge: Gorsuch Areas of Law: Civil Rights, Labor & Employment Law Plaintiff-Appellant Cherie Lopez-Fisher claimed Defendant-Appellee Abbott Laboratories fired her because of her gender, race, color and national origin. [read post]
19 Oct 2011, 11:27 am by Dennis Crouch
In 2005, the Court granted certiorari on related issues in Laboratory Corp. of America v. [read post]
30 Jun 2011, 5:00 am by Bexis
  A bunch of plaintiffs from the United Kingdom sought to sue in the United States, despite their drugs being subject to an entirely different regulatory framework. [read post]